Glycemic Control Among Patients Newly Prescribed IDegLira Across Prior Therapy Group in US Real-World Practice

202018 citationsJournal Articlegold Open Access

Authors

Leonard E. Egede · Medical College of Wisconsin

Abstract

Consistent with previous real-world studies, IDegLira lowered HbA1c across different background prior glucose-lowering therapies, with minimal impact on weight.

Topics & Keywords

Diabetes Treatment and Management Diabetes Management and Research Metabolism, Diabetes, and Cancer

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Therapy

Volume 11, Issue 7, pp. 1579-1589

DOI: 10.1007/s13300-020-00850-w

Field-Weighted Citation Impact: 1.28